It analyzes pathway-level variants that shape baseline GLP-1 biology, offering upstream context for a conversation with your provider rather than serving as any kind of dose-selection tool
It's important to contextualize this concern: No published study has shown BPC-157 causing or promoting tumor growth The body already produces BPC-157-related compounds naturally in gastric juice Many foods and supplements (such as curcumin and certain vitamins) also promote angiogenesis without being considered cancer risks The concern remains theoretical, not evidence-based, but it warrants continued research Out of an abundance of caution, we recommend that individuals with active malignancies consult their oncologist before using BPC-157
Seek urgent medical attention for severe abdominal pain, persistent vomiting, signs of dehydration, or symptoms of hypoglycaemia
GHK-Cu (Glycyl-L-Histidyl-L-Lysine-Copper) is a naturally occurring tripeptide found in human plasma, saliva, and urine
The GLP-1 market is poised for unprecedented growth over the next five years, presenting a unique opportunity for digital health solutions focused on behavior change